Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced that former Nimbus Therapeutics CEO, Jeb Keiper, has joined Strand's Board as an independent Director to ...

PureGym will be maintaining the momentum of its swift rollout next year, with 60 to 65 new sites planned, in line with this ...

The University of Michigan is seen as a back door for Beijing - a soft target for Chinese operatives, covert networks and ...

Next-Generation Biologics and Biosimilars Market to Hit 251.13 billion Dollars by 2033 - Strategic Revenue Insights (SRI) ...

A new genetically modified crop's biosensor uses a method called loop-mediated isothermal amplification to achieve more ...

Discusses Strategic Partnership to Transform Engineering and Design Through AI and Accelerated Computing December 1, 2025 10:00 ...

Topics range from fungal-based building materials and autoimmune diseases to molecular boron chemistry. / €120 million in funding for the first ...

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing ...

The identification of the remains was based on a contemporary osteological analysis, but they were subsequently lost and only ...

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...